BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Company Registration Number:
14158063 (England and Wales)

Unaudited statutory accounts for the year ended 30 June 2023

Period of accounts

Start date: 8 June 2022

End date: 30 June 2023

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Contents of the Financial Statements

for the Period Ended 30 June 2023

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Directors' report period ended 30 June 2023

The directors present their report with the financial statements of the company for the period ended 30 June 2023

Principal activities of the company

The Company’s principal activity during the period under review was that of an investment holding company.



Directors

The directors shown below have held office during the whole of the period from
8 June 2022 to 30 June 2023

Christopher Bond
Paul O'Neill


The director shown below has held office during the whole of the period from
8 June 2022 to 30 June 2023

Bruce Currie


Secretary NSM Corporate Services Limited

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
6 March 2024

And signed on behalf of the board by:
Name: Paul O'Neill
Status: Director

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Profit And Loss Account

for the Period Ended 30 June 2023

13 months to 30 June 2023


£
Turnover: 0
Cost of sales: 0
Gross profit(or loss): 0
Distribution costs: 0
Administrative expenses: ( 1,341 )
Operating profit(or loss): (1,341)
Profit(or loss) before tax: (1,341)
Profit(or loss) for the financial year: (1,341)

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Balance sheet

As at 30 June 2023

Notes 13 months to 30 June 2023


£
Called up share capital not paid: 1
Fixed assets
Intangible assets: 3 459,023
Tangible assets:   0
Investments:   0
Total fixed assets: 459,023
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 0
Investments:   0
Total current assets: 0
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: 4 ( 460,363 )
Net current assets (liabilities): (460,363)
Total assets less current liabilities: (1,339)
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): (1,339)
Capital and reserves
Called up share capital: 1
Share premium account: 0
Other reserves: 0
Profit and loss account: (1,340 )
Total Shareholders' funds: ( 1,339 )

The notes form part of these financial statements

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Balance sheet statements

For the year ending 30 June 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 6 March 2024
and signed on behalf of the board by:

Name: Paul O'Neill
Status: Director

The notes form part of these financial statements

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Intangible fixed assets amortisation policy

    Intangible assets comprises of intellectual property that is held for its investment potential, it is included in the balance sheet at cost. Consideration will be given for annual impairment reviews and carried out if deemed appropriate and economically viable.

    Other accounting policies

    Intangible Assets - Intangible assets comprises of intellectual property that is held for its investment potential, it is included in the balance sheet at cost. Consideration will be given for annual impairment reviews and carried out if deemed appropriate and economically viable.Going Concern - The directors have considered the financial position of the company and since it receives financial support from the ultimate beneficial owner to continue in operational existence for the foreseeable future it is considered appropriate to present these financial statements on a going concern basis. Foreign Currencies - The financial statements have been prepared in Sterling, the reporting currency of the Company. Assets and liabilities in other currencies are translated into Sterling at the rate of exchange ruling at the balance sheet date whilst transactions in other currencies are translated into Sterling at the rate of exchange ruling at the date of the transaction. Gains or losses on currency exchange are recognised in the profit and loss account.Taxation - In response to The Income Tax (Substance Requirements) (Guernsey) (Amendment) Ordinance, 2018 ("the ordinance"), the Directors have reviewed the Company’s affairs in accordance with the prescribed requirements of Economic Substance and found that for the period ended 30 June 2023 the Company was inside scope of the Ordinance having held intellectual property.The company is subject to UK income tax at a rate of 19% on the tax-adjusted income, and UK capital gains tax at a rate of 19% on the tax-adjusted gains arising on disposal of, UK-situs property.Ultimate Controlling Party - The immediate parent company is Hanscan Holdings Limited, a company registered in Guernsey.The ultimate controlling party is Liberation Management Limited as trustee of the Impulse Trust, a trust based in Guernsey.Employees and Directors - The average number of employees during the year was nil.

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

  • 2. Employees

    13 months to 30 June 2023
    Average number of employees during the period 0

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

3. Intangible assets

Goodwill Other Total
Cost £ £ £
Additions 459,023 459,023
Disposals
Revaluations
Transfers
At 30 June 2023 459,023 459,023
Amortisation
Charge for year
On disposals
Other adjustments
At 30 June 2023
Net book value
At 30 June 2023 459,023 459,023

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

4. Creditors: amounts falling due within one year note

13 months to 30 June 2023
£
Bank loans and overdrafts 0
Amounts due under finance leases and hire purchase contracts 0
Trade creditors 0
Taxation and social security 0
Accruals and deferred income 0
Other creditors 460,363
Total 460,363